Cập nhật trong Quản lý Bệnh Nhân Hội Chứng Tim Tâm Phế cấp Tính

Harjola VP, Lassus J, Sionis A, et al. CardShock Study Investigators; GREAT Network. Clinical picture and risk prediction of short-term mortality in cardiogenic shock [published correction appears in Eur J heart fail. 2015;17:984]. Eur J Heart Fail. 2015;17:501–9. https://doi.org/10.1002/ejhf.260. Wayangankar SA, Bangalore S, McCoy LA, et al. Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction: a report from the CathPCI Registry. JACC Cardiovasc Interv. 2016;9:341–51. https://doi.org/10.1016/j.jcin.2015.10.039. •• Thiele H, Akin I, Sandri M, et al. CULPRIT-SHOCK Investigators. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med. 2017;377(25):2419–32 Definitive RCT comparing outcomes with multivessel vs. culprit-only PCI in AMICS. Saad M, Fuernau G, Desch S, et al. Prognostic impact of non-culprit chronic total occlusions in infarct-related cardiogenic shock: results of the randomised IABP-SHOCK II trial. EuroIntervention. 2018;14:306–13. Anderson ML, Peterson ED, Peng SA, Wang TY, Ohman EM, Bhatt DL, et al. Differences in the profile, treatment, and prognosis of patients with cardiogenic shock by myocardial infarction classification: a report from NCDR. Circ Cardiovasc Qual Outcome. 2013;6:708–15. Nguyen HL, Yarzebski J, Lessard D, et al. Ten-year (2001-2011) trends in the incidence rates and short-term outcomes of early versus late onset cardiogenic shock after hospitalization for acute myocardial infarction. J Am Heart Assoc. 2017;6(6). Kolte D, Khera S, Aronow WS, Mujib M, Palaniswamy C, Sule S, et al. Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States. J Am Heart Assoc. 2014;3(1):e000590. •• van Diepen S, Katz JN, Albert NM, et al. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017;136(16):e232–68 Comprehensive summary of AMICS management including a proposed regional system of care for AMICS. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic SHOCK: SHOCK investigators: should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med. 1999;341:625–34. https://doi.org/10.1056/NEJM199908263410901. Fincke R, Hochman JS, Lowe AM, et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol. 2003;41:1087–95. •• Basir MB, Schreiber TL, Grines CL, et al. Effect of early initiation of mechanical circulatory support on survival in cardiogenic shock. Am J Cardiol. 2017;119(6):845–51 Analysis from the cVAD registry showing the impact of delay in MCS insertion on survival. •• Ouweneel DM, Eriksen E, Sjauw KD, et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2017;69(3):278–87 Randomized-controlled trial showing no difference in outcomes with Impella vs. and IABP in AMICS patients. Lauten A, Engström AE, Jung C, Empen K, Erne P, Cook S, et al. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Circ Heart Fail. 2013;6(1):23–30. Poss J, Koster J, Fuernau G, et al. Risk stratification for patients in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2017;69(15):1913–20. Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA. 2006;295(21):2511–5. Dzavik V, Sleeper LA, Cocke TP, Moscucci M, Saucedo J, Hosat S, et al. Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J. 2003;24:828–37. Rogers PA, Daye J, Huang H, Blaustein A, Virani S, Alam M, et al. Revascularization improves mortality in elderly patients with acute myocardial infarction complicated by cardiogenic shock. Int J Cardiol. 2014;172(1):239–41. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force On Practice Guidelines. Circulation. 2013;127(4):e362–425. https://doi.org/10.1161/CIR.0b013e3182742cf6. Romagnoli E, Biondi-Zoccai G, Sciahbasi A, et al. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (radial versus femoral randomized investigation in ST-elevation acute coronary syndrome) study. J Am Coll Cardiol. 2012;60(24):2481–9. Roule V, Lemaitre A, Sabatier R, Lognoné T, Dahdouh Z, Berger L, et al. Transradial versus transfemoral approach for percutaneous coronary intervention in cardiogenic shock: a radial-first centre experience and meta-analysis of published studies. Arch Cardiovasc Dis. 2015;108(11):563–75. Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon pump in cardiogenic shock II (IABP-SHOCK II) trial investigators. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12-month results of a randomized open-label trial. Lancet. 2013;382(9905):1638–45. •• Neumann FJ, Sousa-Uva M, Ahlsson A, et al. ESC Scientific Document Group. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2018. https://doi.org/10.1093/eurheartj/ehy394 Latest European Society of Cardiology/European Association of Cardio-Thoracic Surgery guidelines that recommend performing culprit-only PCI and avoiding routine use of IABP in AMICS. De Backer D, Biston P, Devriendt J, et al. SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362(9):779–89. Stretch R, Sauer CM, Yuh DD, Bonde P. National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis. J Am Coll Cardiol. 2014;64(14):1407–15. •• Mandawat A, Rao SV. Percutaneous mechanical circulatory support devices in cardiogenic shock. Circ Cardiovasc Interv. 2017;10(5):e004337. https://doi.org/10.1161/CIRCINTERVENTIONS.116.004337 Excellent summary on MCS therapy based on shock hemodynamics. •• O'Neill WW, Grines C, Schreiber T, et al. Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device. Am Heart J. 2018;202:33–8 Large study from a national quality improvement database between 2009-2016 showing the pre-PCI insertion of Impella in AMICS was associated with lower mortality. O'Neill WW, Schreiber T, Wohns DH, et al. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. J Interv Cardiol. 2014;27:1–11. •• Basir MB, Schreiber T, Dixon S, et al. Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: the Detroit cardiogenic shock initiative. Catheter Cardiovasc Interv. 2018;91(3):454–61 Prospective multicenter study reporting improved outcomes after implementation of a systematic protocol for managing AMICS patients. Kapur NK et al. The door to unload (DTU) safety and feasibility pilot trial. Presented at the 2018 American Heart Association Late Breaking Clinical Science. Smith L, Peters A, Mazimba S, Ragosta M, Taylor AM. Outcomes of patients with cardiogenic shock treated with TandemHeart (®) percutaneous ventricular assist device: importance of support indication and definitive therapies as determinants of prognosis. Catheter Cardiovasc Interv. 2018;92:1173–81. https://doi.org/10.1002/ccd.27650. Huang CC, Hsu JC, Wu YW, et al. Implementation of extracorporeal membrane oxygenation before primary percutaneous coronary intervention may improve the survival of patients with ST-segment elevation myocardial infarction and refractory cardiogenic shock. Int J Cardiol. 2018;269:45–50. Kagawa E, Dote K, Kato M, Sasaki S, Nakano Y, Kajikawa M, et al. Should we emergently revascularize occluded coronaries for cardiac arrest? Rapid-response extracorporeal membrane oxygenation and intra-arrest percutaneous coronary intervention. Circulation. 2012;126(13):1605–13. Cho S, Lee W, Lim SH, Kang TS. Relationship between clinical outcomes and cardiopulmonary resuscitation time in patients with acute myocardial infarction treated by extracorporeal membrane oxygenation-assisted primary percutaneous coronary intervention. Korean Circ J. 2018;48(8):705–15. Chen YS, Lin JW, Yu HY, Ko WJ, Jerng JS, Chang WT, et al. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet. 2008;372(9638):554–61. •• Atkinson TM, Ohman EM, O'Neill WW, Rab T, Cigarroa JE. Interventional Scientific Council of The American College of Cardiology. A practical approach to mechanical circulatory support in patients undergoing percutaneous coronary intervention: an interventional perspective. JACC Cardiovasc Interv. 2016;9(9):871–83. https://doi.org/10.1016/j.jcin.2016.02.046 Comprehensive summary of MCS selection. Jacobs AK, Leopold JA, Bates E, Mendes LA, Sleeper LA, White H, et al. Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. J Am Coll Cardiol. 2003;41(8):1273–9. Lala A, Guo Y, Xu J, Esposito M, Morine K, Karas R, et al. Right ventricular dysfunction in acute myocardial infarction complicated by cardiogenic shock: a hemodynamic analysis of the should we emergently revascularize occluded coronaries for cardiogenic SHOCK (SHOCK) trial and registry. J Card Fail. 2018;24(3):148–56. https://doi.org/10.1016/j.cardfail.2017.10.009. •• Kapur NK, Esposito ML, Bader Y, et al. Mechanical circulatory support devices for acute right ventricular failure. Circulation. 2017;136(3):314–26. https://doi.org/10.1161/CIRCULATIONAHA.116.025290 Comprehensive summary of hemodynamic variables and MCS strategies for shock due to right ventricular failure. Anderson MB, Goldstein J, Milano C, et al. Benefits of a novel percutaneous ventricular assist device for right heart failure: the prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant. 2015;34(12):1549–60. Brilakis ES, Eckman P. The five key “ingredients” for improving outcomes in cardiogenic shock complicating acute myocardial infarction. Catheter Cardiovasc Interv. 2018;91(3):462–3. https://doi.org/10.1002/ccd.27540. Na SJ, Park TK, Lee GY, et al. Impact of a cardiac intensivist on mortality in patients with cardiogenic shock. Int J Cardiol. 2017;244:220–5. https://doi.org/10.1016/j.ijcard.2017.06.082. Mahmoud AN, Elgendy IY, Mojadidi MK, et al. Prevalence, causes, and predictors of 30-day readmissions following hospitalization with acute myocardial infarction complicated by cardiogenic shock: findings from the 2013-2014 National Readmissions Database. J Am Heart Assoc. 2018;23:7(6).